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SUMMARY
Endovascular aortic/aneurysm repair (EVAR) was introduced into clinical practice at the beginning of the 
nineties. Its fast development had a great influence on clinicians, vascular surgeons and interventional 
radiologists, educational curriculums, patients, industry and medical insurance. The aim of this paper is to 
present the contribution of clinicians and industry to the development and advancement of endovascular 
aortic repair over the last 20 years. This review article presents the development of EVAR by focusing 
on the contribution of physicians, surgeons and interventional radiologists in the creation of the new 
field of vascular surgery termed hybrid vascular surgery, and also the contribution of technological 
advancement by a significant help of industrial representatives – engineers and their counselors. This 
article also analyzes studies conducted in order to compare the successfulness of EVAR with up-to-now 
applied open surgical repair of aortic aneurysms, and some treatment techniques of other aortic diseases. 
During the first two decades of its development the EVAR method was rapidly progressing and was 
adopted concurrently with the expansion of technology. Owing to large randomized studies, early and 
long-term results indicate specific complications of this method, thus influencing further technological 
improvement and defining risk patients groups in whom the use of the technique should be avoided. 
Good results are insured only in centers, specialized in vascular surgery, which have on their disposal 
adequate conditions for solving all complications associated with this method.
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INTRODUCTION
Aortic aneurysms with increasing diameter are 
at risk of rupture. Since 1950 rupture preven-
tion has been achieved by synthetic graft re-
placement of the patient’s aortic segment. Since 
1991 minimal invasive (endovascular) treat-
ment has brought revolution in the treatment of 
aortic aneuyrismal disease. Introduction of this 
method into everyday practice was supported 
by good early results, and tempted with the fact 
that by using this technique thoracotomy and 
laparotomy can be avoided. Evidence-based 
results were continuously preventing overuse 
of this method while waiting for long term out-
come. Fast technical development and perma-
nent improvement of this method, on the other 
side, made trial results interpretation more 
complicated, sometimes providing excuses for 
bad results and at the same time explanations 
for good ones. Recently, after reported results of 
these trials, the European Society for Vascular 
Surgery has published guidelines for the treat-
ment of abdominal aortic aneurysm [1].
PROCEDURE
Abdominal aortic aneurysm exclusion with the 
implantation of the stent graft under fluorosco-
py has been performed for the first time in 1991 
by Juan Parodi, Argentinean vascular surgeon 
[2]. A few years before Nikolai Volodos had per-
formed the first implantation of the stent graft in 
the thoracic aorta [3]. Endovascular treatment 
of different aortic pathology has been used in 
routine practice in Serbia since 2007. Since then 
more than 200 procedures were performed in 
the main Serbian clinics dedicated to the treat-
ment of different aortic disorders. Some of expe-
riences in this field have been already published 
by authors of this manuscript [4-10]. The stent 
graft is a syntethic blood vessel made of stainless 
steel or nitinol (metal alloy of nickel and tita-
nium) for the internal armature, while synthetic 
material made of Dacron or PTFE is used for 
coverage of this armature. With this construc-
tion, when implanted inside the aneurysm, the 
stent graft provides its isolation from the sys-
temic blood pressure as well as rupture preven-
tion. The procedure can be performed under 
general, regional or local anesthesia, and de-
mands placement of the sheaths into the femo-
ral artery (common femoral artery is opened by 
groin cut down or through percutaneous punc-
ture), followed by the introduction of the wires 
that serve as a carrier of the stent graft delivery 
system. When the delivery system is positioned 
in the area of the aneurysm neck, angiography 
is performed to mark and deploy precisely the 
upper limit of the stent graft and the position 
of the most distal vital aortic branch (renal ar-
teries in case of abdominal aortic aneurysm or 
left subclavian artery in case of thoracic aortic 
aneurysm). The stent graft is then released from 
the delivery system and placed across the aortic      
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aneurysm, always fixed on the healthy aortic wall proxi-
mally and distally from the aneurysm.
INDICATIONS
This method has already been accepted worldwide and 
the quantity of its usage mostly depends on the random-
ized trial results, economical situation of the country and 
educational level of the practitioners. Nevertheless, while 
longer and longer term results are to be defined, the endo-
vascular repair is mostly reserved for the patients that are 
at high risk in open surgical treatment, having anatomical 
features suitable for this procedure. While the given nec-
essary anatomical conditions are changing with improve-
ment of technology, the high risk criteria in open surgical 
treatment are estimated by different scales and according 
to different risk factors. In general, there are two groups 
of factors which increase the risk of open repair, requiring 
alternative method of treatment – promoting endovascular 
repair as the method of choice.
The first group involves conditions precluding safe aortic 
cross clamping or surgery in general anesthesia with signifi-
cant blood loss. Those factors are met in patients with severe 
cardio-respiratory co-morbid conditions, which, before en-
dovascular era, would have been rejected from open surgery 
and left to the natural history of the disease – final rupture. 
Renal failure significantly increases the risk of open surgical 
repair, however nephrotoxic contrast usage has to be mini-
mized during endovascular treatment and thus make treat-
ment risks acceptable. Much less frequently seen are factors 
such as hemorrhagic diathesis that makes performance of 
surgery more difficult, or neurological disorders that impede 
recovery. Patients older than 75 years are always at higher 
risk of open surgery regardless of co-morbid conditions.
The second group involves risk factors that hinder ap-
proach to the aneurysm (previous procedure in abdominal 
cavity, retroperiteneum or thorax). The level of limitations 
for open surgery in these cases also depends of the op-
erators experience, however if there is an additional con-
comitant risk factor from the first group, endovascular 
treatment is a preferable treatment option. In the West-
ern countries and North America patients preference or 
insurance company „advice“ play a significant role in the 
process of choosing treatment option.
LIMITS
The process of safe implantation and fixation of the stent 
graft requires that some conditions are satisfied. Those 
conditions are related to the proximal and distal landing 
zone in terms of diameter, length and angulations. The 
aortic segment where the stent graft is fixed serves to 
secure fixation of the stent graft at the desired location. 
This segment is located proximally and distally from the 
aneurysm and is called the “landing zone” (LZ). On the 
other side, the quality of the iliac and femoral arteries as 
an access vessels need to be assessed concerning tortuos-
ity, calcification and diameter in order to allow passage of 
the sheath and delivery system. In reality, it means that 
the endovascular procedure is not possible if the proximal 
and distal LZ are short, angulated or both, and if iliac and 
femoral arteries are too tortuous, calcified or of the lower 
diameter than the outer diameter of the delivery system.
Although this method has brought new revolution to 
the treatment of aneurysms, since the beginning it faced 
these limits and deficiencies that are continually being 
overcome by clinicians on one side and engineers on 
the other. For the last twenty years three generations of 
the stent grafts conquered multiple shortcomings of this 
method, while at the same time vascular surgeons created 
a new hybrid - vascular surgery in order to increase the 
number of treatable patients.
CONTRIBUTION OF CLINICIANS
Fixation of the stent graft is provided by radial force of the 
stent that is oversized to the diameter of the aorta for 10-20%, 
and by the length of the LZ that should be 15 mm for the 
abdominal and 20 mm for the thoracic aorta. Angulations of 
LZ of 75% and more could preclude fixation as well. Hybrid 
procedures have been developed in order to overcome these 
limitations and increase the number of treatable patients.
A common border of the proximal LZ is usually at the 
level of the origin of the left subclavian artery (LSA) for the 
thoracic aorta, and at the level of the origin of most distal 
renal artery (DRA) in case of abdominal aortic aneurysm. 
A significant number of aneurysms start at the level or even 
more proximally from the origin of the LSA and DRA. A 
short LZ in the area of the origin of LSA could be overcome 
by simple covering of the origin of this artery. This maneu-
ver could be complicated, not only by upper limb ischemia, 
but also with stroke and spinal ischemia [11, 12]. Predictors 
of stroke after covering the LSA are occlusive disease of the 
carotid or right vertebral artery, dominant left vertebral artery 
or existence of its origin directly from the aortic arch. Pa-
tients are more susceptible to the development of spinal core 
ischemia when covering more than 250 mm of the length of 
the thoracic aorta, in case of previous reconstruction of the 
abdominal aorta or in case of occlusion of lumbal and hypo-
gastric arteries. All these complications can be prevented by 
revascularization of the LSA with its transposition into the 
left carotid or by a carotido-subclavian bypass (Figure 1). A 
recent meta-analysis has shown that these procedures do not 
prevent stroke; the incidence of spinal cord ischemia could 
be reduced by revascularization of the left subclavian artery 
[13]. Regardless of these facts, the decision to perform revas-
cularization of the LSA is left to the preference of the surgeon.
The problem is weightier when aneurysm is located 
more proximally close to the origin of the left common 
carotid artery. Implantation of the stent graft is pos -
sible only with previous extraanatomic reconstruction 
(carotido-carotid and carotid-LSA bypass), or even if the 
aneurysm is proximal; anatomical reconstruction of su-
praaortic branches is necessary in order to exclude this 
aneurysm with the stent graft (Figure 2). These procedures   
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called “debranching” make possible the treatment of the 
aneurysm of the aortic arch in patients at risk for open 
treatment. However, these procedures are followed by a 
significant number of fatal or non-fatal complications [14].
When the aortic (thoracic or abdominal) aneurysm is 
close to the origin of visceral branches, implantation of 
the endovascular stent graft could compromise flow in 
this vascular bed. In order to provide visceral perfusion, 
besides exclusion of the aneurysm, previous visceral deb-
ranching procedure is performed; hepato-renal, spleno-
renal, iliaco-hepato, splenorenal bypass, or any other kind 
of visceral revascularization with inflow from the healthy 
aorta or iliac arteries (Figure 3) [15]. This type of pro-
cedures are reserved for patients that are at high risk for 
open repair, or in symptomatic patients when waiting for 
the custom made graft is impossible, so the indications for 
these complicated and cumbersome procedures demand-
ing suture of fifteen different anastomoses are narrow [16]. 
If the celiac trunk is the only branch involving the aortic 
aneurysm or the LZ, some authors suggest its covering, but 
it is advisable to perform angiography probe before [17].
Finally, hypogastric arteries are not so frequently remote 
from the aortoiliac aneurysms, and in order to perform 
a safe graft fixation they had to be covered. While some 
authors advocate that this is a safe maneuver even when 
bilateral, others would rather try to provide vascularization 
in order to prevent colon ischemia, gluteal skin necrosis 
or buttock claudication. Bypass or transposition of the hy-
pogastric artery can be performed at least unilaterally to 
provide a minimum pelvic and buttock blood supply after 
extensive aneurysm exclusion with the stent graft [18].
The delivery system is to be placed through the femoral 
and iliac vessels that could be stenotic, occluded or hypo-
plastic, particularly in young adults and women. When 
luminal diameter of the femoral or iliac vessels is smaller 
Figure 1. Control angiography after thoracic stent graft implantation 
and carotid-subclavian bypass (arrow)
Figure 3. A. Reconstruction of aortoiliac segment and revascularization 
of all visceral branches as preparation for stent graft implantation 
covering the visceral segment of the abdominal aorta. B. Control MSCT 
after stent graft implantation
Figure 2. Four-arm Dacron graft sutured proximally for ascending 
aorta and distally in all supraaortic branches     
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than outer diameter of the delivery system, implantation 
of the stent graft is possible with additional construction 
of iliac conduit made of the 10 mm synthetic graft sutured 
to the healthy iliac vessel or distal aorta. After delivering 
the stent graft this conduit can be oversewn at its origin, or 
anastomosed with the ipsilateral femoral artery (Figure 4).
If some of the branches are to be covered accidentally, one 
of the resolutions for this potentially severe complication is 
implantation of the stent (bare or covered) in this branch 
next to the stent graft. Positive results after treatment of this 
complication have enforced clinicians to perform this proce-
dure in elective manner. It was performed for the first time 
in a case of AAA in 2003, and in a case of THAA in 2005, 
while in 2008 M. Malina named it the “Chimney” technique 
[18, 19, 20]. Since then this method has been accepted more 
widely gaining its supporters and opponents [21].
CONTRIBUTION OF THE INDUSTRY
While vascular surgeons and interventionalists were fight-
ing with the limits of the endovascular aneurysm therapy, 
representatives of the industry were developing newer 
generations of stent graft devices requiring fewer limita-
tions and conditions, increasing the number of treatable 
patients. We are describing some of the improvements.
Proximal fixation has been improved by constructing a 
most proximal bare stent that can be placed over renal ar-
teries, the so-called suprarenal fixation, what was later ap-
plied in thoracic stent grafts as well [22]. Additional hooks 
or anchoring barbs in the proximal end of the stent graft 
allowed treatment of patients with shorter and angulated 
necks (Figure 5). Other company provided stent graft with 
anchoring barbs and conical shaped proximal ring adapt-
ing its concavity to the origin of the renal arteries (Figure 
6). Improvement of proximal fixation allocated treatment 
of complicated cases, and dividing the stents provided bet-
ter adaptation on these curvatures, especially at the level of 
iliac arteries, decreasing limb thrombosis rate (Figure 7).
Figure 5. Proximal segment of abdominal stent graft with bare stent 
and anchoring barbs improving proximal fixation
Figure 4. A 10 mm Dacron graft sutured to common iliac artery, pla-
ced under inguinal ligament into the groin to provide passage of the 
delivery system through stenotic iliac segment.
Figure 6. Stent graft with proximal conical ring providing suprarenal 
fixation in 2/3 of circumference
Figure 7. Stent graft with segment iliac limbs improving adaptation 
in elongated iliac arteries  
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Increased flexibility of the delivery system contributed 
to the treatment of patients with a tortuous, stenotic or hy-
poplastic ilio-femoral segment. A new deployment system 
with a top cap and constraining strings allows segmental 
deployment with repositioning of the stent graft when 
needed, which is important in angulated and short ab-
dominal aortic necks, as well as in the great diameter aorta.
Some diseases of the thoracic aorta (penetrating aortic 
ulcer, aortic dissection and traumatic lesions) and some 
anatomical features of the aortic arch and descendent aorta 
demand some corrections and pathology specific improve-
ments of the thoracic stent grafts. Absence of the proximal 
bare stent decreases injury of the fragile dissected aorta, 
increases flexibility and conformability of the stent graft 
in the aortic arch, while longitudinal bars provide bet-
ter columnar strength in this position. Short stent grafts 
and small diameter stent grafts have been constructed 
for traumatic aortic injuries, while stent graft with distal 
bare stent construction keep the true lumen patent when 
acute aortic dissection is treated. All of these corrections 
and innovations have significantly improved results in the 
treatment of acute and chronic specific thoracic aortic  
pathology [23].
One step beyond has been made with construction of 
the fenestrated stent grafts. Scallops and fenestras are con-
structed to keep visceral branches patent for the abdominal 
aneurysms with short proximal and thoracic aortic pathol-
ogy and a short distal LZ. For visceral branches originating 
from the aneurysm sac a stent graft with branches have 
been constructed [24]. By using fenestrated or branched 
stent grafts the necessity for complicated reconstruction 
of the visceral arteries could be avoided. However the us-
age of these stent grafts is also precluded in some cases 
depending on the position and diameter of the visceral 
branches and the distance between each other, aortic and 
lumen diameter. The same technology of the branched 
stent graft has been used to prevent exclusion of the hy-
pogastric arteries [25]. All this represents a great contri-
bution of the industry to increase the number of treatable 
patients, and in the treatment of increasingly complicated 
abdominal and thoracoabdominal aneurysms, but there 
are still some progressions to come. The process of implan-
tation is cumbersome even to the most skilled surgeons. 
The process of production is complex and time consuming 
(4-6 weeks) preventing treatment of urgent and emergent 
cases, while price is higher comparing to the regular stent 
grafts. This technology is not as convenient for aortic arch 
aneurysms as it is for thoracoabdominal, because of the 
unique characteristics of the brain vascularization, how-
ever there is a progress in the creation of solution for this 
complex problem as well [26, 27, 28].
If one of the iliaco femoral sides is unapproachable or 
unusable due to occlusion or severe stenosis, it is possible 
to implant the aorto-uni graft that covers aorta from renal 
to other healthy and patent iliac artery, while blood supply 
for the other limb is provided by a femoro-femoral “cross 
over” bypass (Figure 8).
Another issue is accurate measurement and planning 
of endovascular procedure. Tortuousities that are physi-
ological in the segment of the aortic arch and iliac arteries 
can be encountered in some other areas as well. Axial cross 
sections on the MSCT in these segments are unable to pro-
vide accurate diameter and length of this sector. For these 
purposes dedicated software has been created. Its purpose 
is to allow the clinician to create his own central aortic 
line and to stretch the aorta through this line providing 
an orthogonal section related to this line and not to the 
bogy surface area. With this technique, showed in Figure 
9, diameter and length measurements are more accurate 
especially in elongated segments. Neck length estimation 
and procedure planning are most valuable.
Figure 8. Control MSCT after aorto-uniiliac stent graft implantation 
and femoro-femoral cross over bypass
Končar I. et al. Endovascular Aortic Repair: First Twenty Years     
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RESULTS FROM TRIALS
In order to compare endovascular repair of AAA three 
randomized control trials were organized in Europe, 
Great Britain and United States, while some data “from 
the field” could be taken from registers like EUROSTAR 
in Europe and MEDICARE in the United States. Among 
randomized trials are EVAR 1 and 2 (Endovascular Aneu-
rysm Repair Trial 1 and 2), DREAM (Dutch Randomized 
Endovascular Aneurysm Repair) and OVER study (Open 
Versus Endovascular Aneurysm Repair) [29-34]. Results 
of these studies are correlating with early results being in 
favor of endovascular repair in terms of mortality, mor-
bidity, length of hospitalization and rate of intra-operative 
blood loss. However, during follow-up, this advantage of 
endovascular repair is diminishing after second to forth 
year in all three studies. In the EVAR 1 study this differ-
ence was compensated due to the late death related to 
the implanted stent graft, while in other studies there is 
no difference in the cause of mortality. Late reinterven-
tion rate was higher after endovascular procedure in all 
three studies. Data from the Medicare database showed 
no difference in terms of reintervention rate comparing 
the two procedures. Study following the cause of death 
after aortic repair showed no difference between open 
and endo-repair in 13,971 patients with frequency of 0.3% 
aneurysm related deaths in both groups [35]. High rate of 
reinterventions could be related to the first undeveloped 
generation of stent grafts, measurement (in) accuracy and 
implantation related experience and the learning curve. 
Additionally, reintervention rate could be the conse-
quence of therapeutic over-activity of the practitioners 
included in the study since about 30% of reinterventions 
are due to endoleak type II.
These large studies evaluated cost effectiveness as well. 
Although endovascular procedures are less cost-effective, 
these studies are lacking complete costs analysis. Both 
procedures are bearing long term costs that are difficult 
to follow, estimate and count, like cardiac and renal in-
sufficiency after open repair or costs of follow-up and 
reinterventions after endovascular procedure, meaning 
that new studies are needed to compare these two meth-
ods in terms of cost effectiveness on a long term basis. In 
the meantime clinicians are going to use both methods 
according to the latest results, their skills and advantages 
of newer generation of stent grafts that are hopefully go-
ing to be cheaper.
The latest publications are showing first long term 
results of fenestrated and branched stent grafts in the 
treatment of juxtarenal and thoracoabdominal aortic 
aneurysms [36]. Although these results are very affirma-
tive, they represent good possibilities of new technology, 
however these results are owned by few best high volume 
European centers, and real life results are still about to 
come [37]. However, a French multicentric study presents 
mortality of 3% in 16 university centers. The price of the 
fenestrated and branched stent graft is important fact as 
well, and delivery time is also of value (4-6 weeks).
In case of thoracic aneurysms, avoiding thoracotomy, 
aortic cross clamping and extra corporal circulation thus 
reducing blood loss are obvious advantages that are fa-
voring endovascular versus open repair and reducing 
paraplegia, mortality and morbidity rate. Hospitalization 
length and intensive care unit stay are significantly lower, 
while graft infection rate is still unchanged, 1-3%, with 
mortality of 50-100% [38-41]. Still, some pathological fea-
tures of the descendent thoracic aorta and aortic arch are 
making them prone to different diseases, like dissection, 
dissected aneurysm, traumatic rupture and penetrated 
aortic ulcers, while anatomy of the aortic arch is some-
times making serious limits to endovascular repair. New 
decade of endovascular therapy will bring us resolution 
for these limitations.
CONCLUSION
During the first two decades the endovascular procedure 
has rapidly evolved and technology has been significantly 
improved, while its results are becoming known, differ-
ent complications and risk factors are becoming better de-
fined. The evolution of this technique has changed planes 
of education of young surgeons and its adoption should 
be modified at the level of initial years of surgeons’ educa-
tion. Good results are about to come only in high volume 
centers that are capable of resolving all possible complica-
tions. Current limits are hopefully going to be overcome 
by technological development, decreasing complication 
rate and costs.
Figure 9. A. Streched thoracoabdominal aneurysm with central line 
analysed with working station "Trimensio". B. Measuring the distance 
between different aortic segments.  
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КРАТАК САДРЖАЈ
Ен  до  ва  ску  лар  но ле  че  ње аорт  них ане  у  ри  зми (енгл. en do-
va scu lar aor tic/ane urysm re pa ir – EVAR) у кли  нич  ку прак  су је 
уве  де  но по  чет  ком де  ве  де  се  тих го  ди  на два  де  се  тог ве  ка. Брз 
раз  вој ове ме  то  де зна  чај  но је ути  цао на кли  нич  ке ле  ка  ре, 
про  гра  ме еду  ка  ци  је, бо  ле  сни  ке, ин  ду  стри  ју и здрав  стве  но 
оси  гу  ра  ње. У ра  ду је при  ка  зан до  при  нос кли  нич  ких ле  ка-
ра и пред  став  ни  ка ин  ду  стри  је у раз  во  ју и на  прет  ку EVAR у 
про  те  клих два  де  сет го  ди  на. Опи  са  ни су раз  вој ове ме  то  де, 
до  при  нос ле  ка  ра, хи  рур  га и ин  тер  вент  них ра  ди  о  ло  га, на  ста-
нак но  ве обла  сти ва  ску  лар  не хи  рур  ги  је – хи  брид  не ва  ску-
лар  не хи  рур  ги  је, као и до  при  нос тех  но  ло  шког уса  вр  ша  ва-
ња ко  ји су зна  чај  но пот  по  мо  гли пред  став  ни  ци ин  ду  стри  је 
– ин  же  ње  ри и њи  хо  ви са  вет  ни  ци. У ра  ду се ана  ли  зи  ра  ју и 
сту  ди  је ко  је су упо  ре  ђи  ва  ле успе  шност ме  то  де EVAR са до-
сад при  ме  њи  ва  ним отво  ре  ним хи  рур  шким ле  че  њем аорт-
них ане  у  ри  зми, као и не  ке тех  ни  ке ле  че  ња дру  гих обо  ље  ња 
аор  те. То  ком пр  ве две де  це  ни  је раз  во  ја ова ме  то  да се бр  зо 
раз  ви  ја  ла и усва  ја  ла упо  ре  до с раз  во  јем тех  но  ло  ги  је. За  хва-
љу  ју  ћи ве  ли  ким ран  до  ми  зи  ра  ним сту  ди  ја  ма, ра  ни и уда  ље-
ни ре  зул  та  ти нам ука  зу  ју на спе  ци  фич  не ком  пли  ка  ци  је ове 
ме  то  де, ути  чу  ћи на да  ље уна  пре  ђе  ње тех  но  ло  ги  је и де  фи-
ни  са  ње ри  зич  них гру  па бо  ле  сни  ка код ко  јих при  ме  ну ове 
ме  то  де тре  ба из  бе  га  ва  ти. До  бри ре  зул  та  ти су из  ве  сни са  мо 
у цен  три  ма спе  ци  ја  ли  зо  ва  ним за ва  ску  лар  ну хи  рур  ги  ју, где 
по  сто  је усло  ви за ре  ша  ва  ње свих ком  пли  ка  ци  ја ове ме  то  де.
Кључ  не ре  чи: ане  у  ри  зма аор  те; ен  до  ва  ску  лар  ни трет  ман; 
хи  брид  не про  це  ду  ре; про  цес раз  во  ја
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